C

Co-Diagnostics
D

CODX

1.04500
USD
-0.01
(-0.48%)
Market Closed
Volume
1,153
EPS
-1
Div Yield
-
P/E
-1
Market Cap
33,346,997
OverviewSignalsIdeasNews
Related Instruments
    A
    APT
    0.07000
    (1.34%)
    5.30000 USD
    A
    AYTU
    -0.03000
    (-1.94%)
    1.52000 USD
    B
    BIOC
    -0.09610
    (-18.27%)
    0.42990 USD
    C
    CEMI
    0.02200
    (6.47%)
    0.35000 USD
    N
    NVAX
    0.12000
    (1.67%)
    7.32500 USD
    O
    OPK
    0.01500
    (0.92%)
    1.64500 USD
    Q
    QDEL
    -2.760
    (-7.08%)
    36.210 USD
    T
    TTOO
    -0.00300
    (-0.57%)
    0.52000 USD
    V
    VXRT
    -0.05030
    (-7.97%)
    0.58050 USD
    More
News

Title: Co/Diagnostics

Sector: Healthcare
Industry: Medical Devices
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detectionand/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.